Literature DB >> 13629130

Late prognosis of chlorpromazine jaundice.

A G MELROSE, J R ROY.   

Abstract

Entities:  

Keywords:  AUNDICE/etiology and pathogenesis; CHLORPROMAZINE/injurious effects

Mesh：

Substances：

Year:  1959        PMID： 13629130      PMCID： PMC1992871          DOI： 10.1136/bmj.1.5125.818

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Chlorpromazine jaundice in a general hospital.

Authors:  G S GRAHAM
Journal:  Br Med J       Date:  1957-11-09

2.  Study of chlorpromazine jaundice, its mechanism and prevention; special reference to serum alkaline phosphatase and glutamic oxalacetic transaminase.

Authors:  H SHAY; H SIPLET
Journal:  Gastroenterology       Date:  1957-04       Impact factor: 22.682

3.  Chlorpromazine jaundice.

Authors:  J R KELSEY; J H MOYER; W G BROWN; H D BENNETT
Journal:  Gastroenterology       Date:  1955-11       Impact factor: 22.682

4.  Chlorpromazine jaundice; analysis of twenty-two cases.

Authors:  J L WERTHER; B I KORELITZ
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

5.  Prolonged jaundice (over three months) occurring during chlorpromazine administration.

Authors:  I B BRICK; S V BUCKLEY
Journal:  Gastroenterology       Date:  1957-08       Impact factor: 22.682

6.  Effect of chlorpromazine on the liver.

Authors:  L G BARTHOLOMEW; J G CAIN; S H FRAZIER; M C PETERSEN; W T FOULK; E H SOULE; G A FLEISHER; C A OWEN
Journal:  Gastroenterology       Date:  1958-06       Impact factor: 22.682

7.  Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothrombinemia, and the development of portal hypertension.

Authors:  J D MYERS; R E OLSON; J H LEWIS; T J MORAN
Journal:  Trans Assoc Am Physicians       Date:  1957
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.